Biomarker may predict if immunotherapy is right choice for colorectal cancer patients
DUARTE, Calif. — Foundational research by a City of Hope physician-scientist and his colleagues could one day help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as their first treatment option. “Immunotherapy is the new, hot thing, but sometimes traditional chemotherapy can be a better choice,” said Marwan Fakih, M.D., senior author…